CJC 1295 SIN DAC | IPAMORELINA 10mg

Buy CJC-1295/Ipamorelin 5mg/5mg Blend Research Peptide Online

CJC-1295/Ipamorelin 5mg/5mg Blend Peptide Identification

This dual-peptide combination delivers CJC-1295 (29-amino-acid Modified GRF 1-29) and ipamorelin (5-amino-acid growth hormone secretagogue) in a 1:1 mass ratio (5mg each component per vial, 10mg total). The formulation pairs GHRH receptor agonism with GH secretagogue receptor (GHSR-1a) activation, enabling integrated preclinical investigation of complementary GH axis signaling mechanisms. Supplied as lyophilized powder blend.

CJC-1295/Ipamorelin 5mg/5mg Blend Mechanism of Action

In cellular and animal research models, this combination engages dual GH-axis pathways simultaneously: CJC-1295 activates GHRH receptor 1a signal cascades while ipamorelin stimulates ghrelin receptor (GHSR-1a) signaling. The combination permits investigation of synergistic growth hormone secretion patterns through distinct receptor mechanisms. Cell culture studies demonstrate complementary somatotroph activation when both pathways are engaged concurrently in controlled laboratory systems.

CJC-1295/Ipamorelin 5mg/5mg Blend Published Research Summary

Raun et al. (2000) characterized CJC-1295 GHRH pharmacology; Raun et al. (1998, European Journal of Pharmacology) established ipamorelin GHSR-1a selectivity. Liu et al. (2017, Frontiers in Endocrinology) documented synergistic GH secretion when GHRH and ghrelin pathways are activated simultaneously in animal models. Preclinical literature indicates combined GHRH/GHSR agonism produces enhanced GH responses in tissue-specific research systems.

CJC-1295/Ipamorelin 5mg/5mg Blend Product Specifications & Handling

Form: Lyophilized powder blend, white; Total Quantity: 10mg (5mg CJC-1295 + 5mg ipamorelin); Storage: -20°C, desiccated, light-protected, sealed; Reconstitution: Sterile saline or bacteriostatic water; Stability: 24 months from manufacture; Purity: >99% for each peptide by HPLC; Single vial format.

CJC-1295/Ipamorelin 5mg/5mg Blend Research Use Only Disclaimer

Research use only. Not for human consumption, clinical application, medical diagnosis, disease treatment, or therapeutic claims. All described mechanisms are based on controlled preclinical research. Institutional review board compliance and regulatory authorization required.